TGSA: protein-protein association-based twin graph neural networks for drug response prediction with similarity augmentation.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
03 01 2022
Historique:
received: 17 06 2021
revised: 16 08 2021
accepted: 24 09 2021
pubmed: 25 9 2021
medline: 3 2 2023
entrez: 24 9 2021
Statut: ppublish

Résumé

Drug response prediction (DRP) plays an important role in precision medicine (e.g. for cancer analysis and treatment). Recent advances in deep learning algorithms make it possible to predict drug responses accurately based on genetic profiles. However, existing methods ignore the potential relationships among genes. In addition, similarity among cell lines/drugs was rarely considered explicitly. We propose a novel DRP framework, called TGSA, to make better use of prior domain knowledge. TGSA consists of Twin Graph neural networks for Drug Response Prediction (TGDRP) and a Similarity Augmentation (SA) module to fuse fine-grained and coarse-grained information. Specifically, TGDRP abstracts cell lines as graphs based on STRING protein-protein association networks and uses Graph Neural Networks (GNNs) for representation learning. SA views DRP as an edge regression problem on a heterogeneous graph and utilizes GNNs to smooth the representations of similar cell lines/drugs. Besides, we introduce an auxiliary pre-training strategy to remedy the identified limitations of scarce data and poor out-of-distribution generalization. Extensive experiments on the GDSC2 dataset demonstrate that our TGSA consistently outperforms all the state-of-the-art baselines under various experimental settings. We further evaluate the effectiveness and contributions of each component of TGSA via ablation experiments. The promising performance of TGSA shows enormous potential for clinical applications in precision medicine. The source code is available at https://github.com/violet-sto/TGSA. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 34559177
pii: 6374919
doi: 10.1093/bioinformatics/btab650
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-468

Subventions

Organisme : National Research and Development Program of China
ID : 2019YFC0118802
Organisme : Key R & D Program of Zhejiang Province
ID : 2020C03010
Organisme : National Natural Science Foundation of China
ID : 61672453
Organisme : Zhejiang University Education Foundation
ID : K18-511120-004
Organisme : Zhejiang public welfare technology research project
ID : LGF20F020013
Organisme : Medical and Health Research Project of Zhejiang Province of China
ID : 2019KY667
Organisme : Wenzhou Bureau of Science and Technology of China
ID : Y2020082
Organisme : Key Laboratory of Medical Neurobiology of Zhejiang Province
Organisme : National Science Foundation
ID : CCF-1617735

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Yiheng Zhu (Y)

College of Computer Science and Technology, Zhejiang University, Hangzhou 310000, China.

Zhenqiu Ouyang (Z)

Polytechnic Institute, Zhejiang University, Hangzhou 310000, China.

Wenbo Chen (W)

Polytechnic Institute, Zhejiang University, Hangzhou 310000, China.

Ruiwei Feng (R)

College of Computer Science and Technology, Zhejiang University, Hangzhou 310000, China.

Danny Z Chen (DZ)

Department of Computer Science and Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.

Ji Cao (J)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310000, China.

Jian Wu (J)

Department of Ophthalmology of the Second Affiliated Hospital School of Medicine, and School of Public Health, Zhejiang University, Hangzhou 310000, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH